Dubbed Elsa, the tool was expected to roll out at the end of June. The FDA says it marks the dawn of a new era. Reading time 2 minutes Generative artificial intelligence has found another home in the ...
Add Yahoo as a preferred source to see more of our stories on Google. Sadly, Mama Elsa passed away in 2019. In a statement, the Patton family said, “Our beloved Elsa Patton (aka Mama Elsa) passed away ...
The U.S. Food and Drug Administration on Monday announced the launch of a new generative AI technology that agency leaders said will help its employees do their jobs more efficiently. The tool, called ...
The FDA is using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations and identify high-priority inspection targets. The Food and Drug Administration has ...
The U.S. Food and Drug Administration (FDA) has launched Elsa, an AI tool designed to modernize and speed up agency-wide operations ranging from scientific reviews to investigations. Marty Makary, the ...
Hosted on MSN
AI at the FDA: help or hindrance?
The advent of AI at the US Food and Drug Administration (FDA) is changing the complexion of the regulatory approval process for medical devices. In May, FDA commissioner Dr Martin Makary announced ...
As AI becomes a core part of FDA oversight, companies who prepare now will have a distinct market advantage. This isn’t just about compliance, it’s about accelerating innovation and commercialization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results